Question 1

How does EquitAI evaluate Knowles Corporation's (KN) valuation and Stock DNA?

Accepted Answer

Knowles Corporation (KN) trades at $32.87 with an EquitAI Valuation DNA score of 4/10 and Quality score of 9/10. The company's trailing P/E ratio is 39.1x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

Question 2

What sector and industry does Knowles Corporation (KN) operate in?

Accepted Answer

Knowles Corporation (KN) is classified under the Technology sector within the Hardware, Equipment & Parts industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Hardware, Equipment & Parts peers and broader Technology market benchmarks.

Question 3

What is Wall Street's price target and consensus rating for Knowles Corporation (KN)?

Accepted Answer

Wall Street analysts have a consensus 12-month price target of $42.5 for Knowles Corporation (KN), representing an implied 29.3% upside from its current trading level of $32.87 with an average rating of Buy based on 2 analyst ratings. Individual analyst price targets range from a low of $35.0 to a high of $50.0, with a median forecast of $42.5. EquitAI benchmarks analyst consensus projections against intrinsic Financial DNA valuation pillars.

Question 4

Does KN pay dividends or capital distributions?

Accepted Answer

Knowles Corporation does not currently pay a regular dividend yield, prioritizing capital reinvestment into operations, product development, and balance sheet strength.

Question 5

Who are Knowles Corporation's (KN) primary market competitors and peers?

Accepted Answer

Key market peers and semantic competitors include VSH, CTS, KE, KOSS. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

Question 6

How should investors interpret EquitAI's KN analysis?

Accepted Answer

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

KN - Knowles Corporation Stock Analysis & Valuation

Knowles Corporation

FIT ANALYSIS